Results 111 to 120 of about 114,683,953 (299)

Adult‐Onset Dystonia Related to PRKRA (DYT16): A Predictor of Favorable Deep Brain Stimulation Outcome

Movement Disorders Clinical Practice, EarlyView.
Ingrid Lorena da Silva Gomes, Eduardo Drews Amorim, Juan Sebastián Sánchez León, Thomas Hugentobler Schlickmann, Yuri Ferreira Felloni Borges, Artur Francisco Schumacher Schuh, Daniel Teixeira‐dos‐Santos, Sheila Trentin, Thais Lampert Monte, Bruno Samuel Fraiman de Oliveira   +9 more
wiley   +1 more source

Mirabegron and Intradetrusor Onabotulinumtoxina for Overactive Bladder in Parkinson's Disease: A Systematic Review and Meta‐Analysis

Neurourology and Urodynamics, EarlyView.
ABSTRACT Objective To synthesize the evidence on the efficacy and safety of mirabegron and intradetrusor onabotulinumtoxinA (BoNT‐A) as separate interventions for overactive bladder (OAB) in Parkinson's disease (PD). Methods A systematic review and meta‐analysis with parallel synthesis of two distinct interventions was conducted of randomized and ...
Hussain Arshad, Raiyana Nuha, Shehab Khashaba, David Gillatt, Simon J. G. Lewis   +4 more
wiley   +1 more source

Advancing Personalized Care for Neurogenic Bladder: The Case for Continent Urinary Diversion

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Neurogenic lower urinary tract dysfunction (NLUTD) with a poorly compliant bladder that is refractory to minimally invasive therapies (MIT) represents an “end‐stage” phenotype in which the principal objectives are durable upper urinary tract protection and restoration of continence with acceptable long‐term morbidity.
Francis A. Jefferson, Maude E. Carmel
wiley   +1 more source

From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction

Toxins
Since its regulatory approval over a half-century ago, botulinum toxin has evolved from one of the most potent neurotoxins known to becoming routinely adopted in clinical practice.
Lucas Rempel, Raza N. Malik, Claire Shackleton, Martín Calderón-Juárez, Rahul Sachdeva, Andrei V. Krassioukov   +5 more
doaj   +1 more source

Korean botulinum toxins

Journal of Neural Transmission
Abstract Botulinum toxin (BT) is used therapeutically since the late 1980s. For many years, BT drugs were provided by a small group of manufacturers from Europe and the United States. As BT’s use for aesthetic purposes surged, numerous new manufacturers entered the field, particularly from Korea.
Dirk, Dressler, Nayoung, Kim, Eric A, Johnson, Fereshte, Adib Saberi   +3 more
openaire   +2 more sources

Urodynamic Voiding Patterns in Multiple Sclerosis

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims This study aimed to describe urodynamic voiding patterns in patients with MS (PwMS) using standardized assessments, and to compare the performance of the available nomograms and indices for obstruction and bladder contractility. Methods PwMS and lower urinary tract symptoms underwent cystometry and pressure flow studies.
Camille Chesnel, Nicolas Turmel, Maelys Teng, Emilie Blouet, Gérard Amarenco, Claire Hentzen   +5 more
wiley   +1 more source

Botulinum toxin type A success rates and predictive factors for favourable outcomes in paediatric patients with acquired esotropia.

PLoS ONE
PurposeThis study aimed to assess the efficacy of botulinum toxin type A in treating childhood-acquired comitant esotropia and identify predictive factors of treatment success.MethodsThis retrospective, consecutive, non-comparative cohort study included ...
Narisa Rattanalert, Teechaya Nonboonyawat, Supaporn Tengtrisorn, Penny Singha, Orapan Aryasit, Juthamat Witthayaweerasak, Manupol Tangthongkum   +6 more
doaj   +1 more source

The Benefits of Adding Non‐Antimuscarinic Pharmaceuticals in Combination With Beta‐3 Agonists for Overactive Bladder Treatment: A Systematic Review

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Antimuscarinics, as the current first‐line pharmacologic therapies for overactive bladder, exhibit low patient adherence and high rates of reported side effects. As a modern alternative pharmaceutical treatment, beta‐3 agonists, which relax the urinary bladder, may be more tolerable for patients, increasing adherence and ...
Felicity Smith, Charlotte Phelps, Christian Moro   +2 more
wiley   +1 more source

Capsaicin protects neuromuscular junctions from the inhibitory effects of botulinum neurotoxin A [PDF]

, 2008
Within 24 hrs after injecting botulinum neurotoxin A (BoNT/A) into the hindlimb, mice lost the toe spread reflex and developed progressive muscle weakness. At the same time, the compound muscle action potential amplitude decreased. Injection of capsaicin
Carmen Garcia, Joseph McArdle, Kormakur Hognason, Joseph Potian, Baskaran Thyagarajan, Natalia Krivitskaya   +5 more
core  

Nutritional status and functions in children with cerebral palsy at different gestational ages

Pediatric Investigation, EarlyView.
The nutritional status of cerebral palsy was significantly associated with their motor, eating and drinking ability, and their ability of daily living in the 28–32‐week and the ≥37‐week gestational age group, whereas in 33–36‐week group, correlation was only observed between the nutritional status and eating and drinking ability.
Hongmei Tang, Qihong Wu, You Wang, Tingting Peng, Yiting Zhao, Jie Luo, Yaodan Liang, Kaiyin Cai, Linlin Wu, Qinyan Wu, Hongyu Zhou, Yiming Qiu, Jinling Li, Lu He, Kaishou Xu   +14 more
wiley   +1 more source